{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:34:12Z","timestamp":1793126052356,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010429","name":"Erasmus MC Vriendenfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107643","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:26:33Z","timestamp":1787495193000},"page":"107643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel dual-targeted gastrin-releasing peptide receptor and fibroblast activation protein radiopharmaceuticals for molecular imaging of heterogeneous breast tumors"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3848-1917","authenticated-orcid":false,"given":"Priciana","family":"Para\u00efso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7307-0388","authenticated-orcid":false,"given":"Hanyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Illi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2328-9313","authenticated-orcid":false,"given":"Amber","family":"Piet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryana","family":"Handula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrina","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Stuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien H.M.","family":"van Deurzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Seimbille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107643_bib0022","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/acs.bioconjchem.5b00665","article-title":"Measuring and suppressing the oxidative damage to DNA during Cu(I)-catalyzed azide\u2013Alkyne cycloaddition","volume":"27","author":"Abel","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0001","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.3390\/molecules181113148","article-title":"Peptide conjugation via CuAAC \u201cclick\u201d chemistry","volume":"18","author":"Ahmad Fuaad","year":"2013","journal-title":"Molecules. Switzerland;"},{"key":"10.1016\/j.ejps.2026.107643_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2967\/jnumed.120.244806","article-title":"The latest developments in imaging of fibroblast activation protein","volume":"62","author":"Altmann","year":"2021","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.ejps.2026.107643_bib0003","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2967\/jnumed.120.259630","article-title":"Results from 50 patients with biochemically recurrent prostate cancer","volume":"62","author":"Baratto","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0004","first-page":"79","article-title":"Molecular imaging of bombesin receptors in various tumors by Ga-68 AMBA PET\/CT: first results","volume":"48","author":"Baum","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0005","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1002\/anie.201101817","article-title":"Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study","volume":"50","author":"Besanceney-Webler","year":"2011","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejps.2026.107643_bib0006","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0016-5085(93)91062-M","article-title":"Expression of bombesin-receptor subtypes and their differential regulation of colonic smooth muscle contraction","volume":"105","author":"Bitar","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2026.107643_bib0007","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2174\/1568026611212230005","article-title":"Effectiveness of quenchers to reduce radiolysis of 111In or 177Lu labelled methionin-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC","volume":"12","author":"Blois","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0008","article-title":"Design and synthesis of (68)Ga-labeled peptide-based heterodimers for dual targeting of NTS(1) and GRPR","volume":"20","author":"Bodin","year":"2025","journal-title":"ChemMedChem. Germany;"},{"key":"10.1016\/j.ejps.2026.107643_bib0009","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1007\/s00259-022-05933-3","article-title":"Hetero-bivalent agents targeting FAP and PSMA","volume":"49","author":"Boinapally","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2026.107643_bib0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10967-014-3248-1","article-title":"Determination of peptide content and purity of DOTA-peptides by metal ion titration and UPLC: an alternative method to monitor quality of DOTA-peptides","volume":"302","author":"Breeman","year":"2014","journal-title":"J. Radioanaly. Nuclear Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s41181-024-00272-0","article-title":"eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors","volume":"9","author":"Chapeau","year":"2024","journal-title":"EJNMMI. Radiopharm. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7150\/thno.13580","article-title":"In vivo stabilization of a gastrin-releasing peptide receptor antagonist enhances PET imaging and radionuclide therapy of prostate cancer in preclinical studies","volume":"6","author":"Chatalic","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2026.107643_bib0013","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1039\/C6OB00932H","article-title":"Arginine side-chain modification that occurs during copper-catalysed azide\u2013alkyne click reactions resembles an advanced glycation end product","volume":"14","author":"Conibear","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0014","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/annonc\/mdm058","article-title":"Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy","volume":"18","author":"Cornelio","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejps.2026.107643_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejps.2026.107643_bib0016","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1007\/s00259-023-06364-4","article-title":"Side-by-side comparison of the two widely studied GRPR-radiotracers, radiolabeled NeoB and RM2, in a preclinical setting","volume":"50","author":"Damiana","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2026.107643_bib0017","first-page":"10","article-title":"Characterization of cancer stroma markers: in Silico analysis of an mRNA expression database for fibroblast activation protein and endosialin","volume":"5","author":"Dolznig","year":"2005","journal-title":"Cancer Immun."},{"key":"10.1016\/j.ejps.2026.107643_bib0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nucmedbio.2013.11.006","article-title":"A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-ahx-RM2] \u03b1v\u03b23\/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors","volume":"41","author":"Durkan","year":"2014","journal-title":"Nucl. Med. Biol. United States;"},{"key":"10.1016\/j.ejps.2026.107643_bib0019","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/molecules24162878","article-title":"Stability evaluation and stabilization of a gastrin-releasing peptide receptor (GRPR) targeting imaging pharmaceutical","volume":"24","author":"Ghosh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107643_bib0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/acsmedchemlett.7b00125","article-title":"Synthesis of a fluorescently labeled 68Ga-DOTA-TOC analog for somatostatin receptor targeting","volume":"8","author":"Ghosh","year":"2017","journal-title":"ACS. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2026.107643_bib0021","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2967\/jnumed.116.187971","article-title":"A modular dual-labeling scaffold that retains agonistic properties for somatostatin receptor targeting","volume":"58","author":"Ghosh","year":"2017","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0023","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0002-9440(10)65525-3","article-title":"Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast","volume":"155","author":"Gugger","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2026.107643_bib0024","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00259-025-07108-2","article-title":"FAP-targeted PET\/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management","volume":"52","author":"Guo","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2026.107643_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41181-024-00283-x","article-title":"In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions","volume":"9","author":"Heide","year":"2024","journal-title":"EJNMMI. Radiopharm. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0026","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/bc800157h","article-title":"Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks","volume":"19","author":"Hohne","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0027","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1002\/anie.200905087","article-title":"Analysis and optimization of copper-catalyzed azide\u2013Alkyne cycloaddition for bioconjugation","volume":"48","author":"Hong","year":"2009","journal-title":"Angew. Chem., Int. Ed."},{"issue":"3","key":"10.1016\/j.ejps.2026.107643_bib0028","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/pharmaceutics15030796","article-title":"Effect of N-terminal peptide modifications on In vitro and In vivo properties of 177Lu-labeled peptide analogs targeting CCK2R","volume":"15","author":"H\u00f6rmann","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107643_bib0029","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/ph15030383","article-title":"Radiosynthesis and preclinical evaluation of bispecific PSMA\/FAP heterodimers for tumor imaging","volume":"15","author":"Hu","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2026.107643_bib0030","article-title":"FAPI-PET\/CT in cancer imaging: a potential novel molecule of the century","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107643_bib0031","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/jo802097m","article-title":"Peptide cyclization and cyclodimerization by CuI-mediated Azide\u2212alkyne cycloaddition","volume":"74","author":"Jagasia","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0032","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of Fibroblast activation protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2026.107643_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.107.07108","article-title":"International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states","volume":"60","author":"Jensen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2026.107643_bib0034","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-12-3490","article-title":"In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548","volume":"19","author":"K\u00e4hkonen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107643_bib0035","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2026.107643_bib0036","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00259-021-05423-y","article-title":"High fibroblast- activation-protein expression in castration- resistant prostate cancer supports the use of FAPI-Molecular theranostics","volume":"49","author":"Kesch","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2026.107643_bib0037","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.trecan.2020.01.010","article-title":"Understanding the cause and consequence of tumor heterogeneity","volume":"6","author":"Khatib","year":"2020","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.ejps.2026.107643_bib0038","first-page":"801","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0039","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13550-026-01390-3","article-title":"Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET\/CT uptake in luminal-like vs. HER2-positive breast cancer","volume":"16","author":"K\u00fcper","year":"2026","journal-title":"EJNMMI. Res."},{"key":"10.1016\/j.ejps.2026.107643_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00259-019-04504-3","article-title":"First-in-human dosimetry of\u2014Gastrin- releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer","volume":"47","author":"Kurth","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejps.2026.107643_bib0041","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1002\/cncr.31079","article-title":"Neuroendocrine tumors and fibrosis: an unsolved mystery?","volume":"123","author":"Laskaratos","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejps.2026.107643_bib0042","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1021\/acs.bioconjchem.6b00267","article-title":"Extent of the oxidative side reactions to peptides and proteins during the CuAAC reaction","volume":"27","author":"Li","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0043","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/bc9000189","article-title":"In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites","volume":"20","author":"Linder","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0044","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Developmentof quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0045","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2026.107643_bib0046","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/cancers15020442","article-title":"Preclinical characterisation of PSMA\/GRPR-targeting heterodimer [(68)Ga]Ga-BQ7812 for PET diagnostic imaging of prostate cancer: a step towards clinical translation","volume":"15","author":"Lundmark","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2026.107643_bib0047","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acs.bioconjchem.5c00218","article-title":"Revolutionizing solid tumor surgery with fibroblast activation protein (FAP)-targeted imaging probes for a fluorescence-guided surgery of pancreatic cancer","volume":"36","author":"Ma","year":"2025","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0048","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acs.bioconjchem.9b00252","article-title":"Development of bispecific NT-PSMA heterodimer for prostate cancer imaging: a potential approach to address tumor heterogeneity","volume":"30","author":"Ma","year":"2019","journal-title":"Bioconjug Chem. United States;"},{"key":"10.1016\/j.ejps.2026.107643_bib0049","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1158\/1078-0432.CCR-08-3145","article-title":"Evaluation of a 1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides","volume":"15","author":"Mansi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107643_bib0050","first-page":"1152","article-title":"Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation","volume":"59","author":"Markwalder","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2026.107643_bib0051","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2967\/jnumed.112.118695","article-title":"99mTc radiotracers based on human GRP (18\u201327): synthesis and comparative evaluation","volume":"54","author":"Marsouvanidis","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0052","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.semnuclmed.2025.01.001","article-title":"Diagnostic value of gastrin-releasing peptide receptor-targeted PET imaging in oncology: a systematic review","volume":"55","author":"Mohseninia","year":"2025","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0053","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2967\/jnumed.116.188011","article-title":"Expression of gastrin-releasing peptide receptor in breast cancer and its association with pathologic, biologic, and clinical parameters: a study of 1432 primary tumors","volume":"58","author":"Morgat","year":"2017","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210905","article-title":"Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples","volume":"14","author":"Morgat","year":"2019","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2026.107643_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.116.178889","article-title":"Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist NeoBOMB1: preclinical and first clinical results","volume":"58","author":"Nock","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0056","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2967\/jnumed.113.129411","article-title":"To serve and protect\u201d: enzyme inhibitors as radiopeptide escorts promote tumor targeting","volume":"55","author":"Nock","year":"2014","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0057","article-title":"Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art. EJNMMI Radiopharmacy and Chemistry","volume":"11","author":"Para\u00efso","year":"2026","journal-title":"[Internet]"},{"key":"10.1016\/j.ejps.2026.107643_bib0058","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/9780470559277.ch110148","article-title":"Copper-catalyzed azide\u2013Alkyne click chemistry for bioconjugation","volume":"3","author":"Presolski","year":"2011","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.ejps.2026.107643_bib0059","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bjc.1995.210","article-title":"High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa","volume":"71","author":"Preston","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2026.107643_bib0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nucmedbio.2021.03.005","article-title":"68Ga]Ga-iPSMA-Lys3-bombesin: biokinetics, dosimetry and first patient PET\/CT imaging","volume":"96-97","author":"Rivera-Bravo","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2026.107643_bib0061","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2967\/jnumed.123.266798","article-title":"68Ga-FAPI PET\/CT as an alternative to 18F-FDG PET\/CT in the imaging of invasive lobular breast carcinoma","volume":"65","author":"Sahin","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2026.107643_bib0062","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","author":"Scanlan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2026.107643_bib0063","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.88.23.10662","article-title":"CD10\/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung","volume":"88","author":"Shipp","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2026.107643_bib0064","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500128","article-title":"Two targets, one mission: heterobivalent metal-based radiopharmaceuticals for prostate cancer imaging and therapy","volume":"20","author":"Sobral","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2026.107643_bib0065","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7150\/thno.14958","article-title":"Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET","volume":"6","author":"Stoykow","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2026.107643_bib0066","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Advanc. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107643_bib0067","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2026.107643_bib0068","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.humpath.2013.06.016","article-title":"Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in Human breast cancer","volume":"44","author":"Tchou","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejps.2026.107643_bib0069","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.advms.2015.04.006","article-title":"Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro","volume":"60","author":"Teichgr\u00e4ber","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.ejps.2026.107643_bib0070","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1074\/jbc.M209764200","article-title":"Sequence identification and characterization of human carnosinase and a closely related non- specific dipeptidase","volume":"278","author":"Teufel","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2026.107643_bib0071","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107643_bib0072","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ph11030065","article-title":"Design, synthesis, In vitro, and initial In vivo evaluation of heterobivalent peptidic ligands targeting both NPY(Y1)- and GRP-receptors\u2014an improvement for breast Cancer imaging?","volume":"11","author":"Vall-Sagarra","year":"2018","journal-title":"Pharmaceuticals [Internet]"},{"issue":"1","key":"10.1016\/j.ejps.2026.107643_bib0073","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41181-024-00283-x","article-title":"In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions","volume":"9","author":"van der Heide","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.ejps.2026.107643_bib0074","first-page":"219","article-title":"Gastrin-releasing peptide (GRP) analogues for cancer imaging","volume":"19","author":"Varvarigou","year":"2004","journal-title":"Cancer BiOther Radiopharm."},{"key":"10.1016\/j.ejps.2026.107643_bib0075","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/molecules28031088","article-title":"Synthesis and preclinical evaluation of three novel 68Ga-labeled bispecific PSMA\/FAP-targeting tracers for prostate cancer imaging","volume":"28","author":"Verena","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107643_bib0076","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/acs.molpharmaceut.2c01000","article-title":"Preclinical evaluation of a fibroblast activation protein and a prostate-specific membrane antigen dual-targeted probe for noninvasive prostate cancer imaging","volume":"20","author":"Wang","year":"2023","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107643_bib0077","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MED.0b013e32831cf5aa","article-title":"Regulation and signaling of human bombesin receptors and their biological effects","volume":"16","author":"Weber","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"10.1016\/j.ejps.2026.107643_bib0078","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2026.107643_bib0079","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00259-024-06634-9","article-title":"Synthesis, preclinical, and initial clinical evaluation of integrin \u03b1(V)\u03b2(3) and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [(68)Ga]Ga-RGD-RM26-03","volume":"51","author":"Wen","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging. Germany;"},{"key":"10.1016\/j.ejps.2026.107643_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111517","article-title":"Nanobody-based radiotracers in nuclear medicine: advances, challenges, and future perspectives","volume":"37","author":"Yao","year":"2026","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejps.2026.107643_bib0081","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","article-title":"Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor- expressing tumors","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2026.107643_bib0082","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/thno.22601","article-title":"(68)Ga-BBN-RGD PET\/CT for GRPR and integrin \u03b1(v)\u03b2(3) imaging in patients with breast cancer","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics Australia;"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:54:13Z","timestamp":1793123653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":82,"alternative-id":["S0928098726002174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107643","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel dual-targeted gastrin-releasing peptide receptor and fibroblast activation protein radiopharmaceuticals for molecular imaging of heterogeneous breast tumors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107643"}}